D02.0 - Carcinoma in situ of larynx
- Applicable to Carcinoma in situ of larynx
- The 2025 edition of ICD10-CM D02.0 became effective on October 1, 2024.
- This is the American ICD10-CM version of D02.0 - other international versions of ICD10 D02.0 may differ.
- D02.0 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
- Carcinoma in situ of epiglottis (suprahyoid portion)
Type 1 Excludes
- carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
- carcinoma in situ of hypopharyngeal aspect (D00.08)
- carcinoma in situ of marginal zone (D00.08)
Billable/Specific Code
The following codes above D02.0 contain annotation back-references that may be applicable to D02.0:
- Chapter: C00-D49 - Neoplasms
- Section: D00-D09 - In situ neoplasms
- Category: D02 - Carcinoma in situ of middle ear and respiratory system
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com